Monika Engelhardt Selected Research

Neoplasms (Cancer)

1/2024	Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.
11/2023	Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT.
1/2023	[Differences due to socio-economic status, genetic background and sex in cancer and precision medicine - An intersectional approach to close the care gap for marginalized groups].
11/2022	Diffuse Bone Marrow Involvement of Multiple Myeloma on [ 18 F]PSMA-1007 PET/CT : Is There a Theranostic Potential?
1/2022	The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and Therapy.
9/2021	Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study.
1/2021	European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma.
1/2021	Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From Germany.
1/2021	Targeting mitotic exit in solid tumors.
1/2018	Pomalidomide.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monika Engelhardt Research Topics

Disease

74	Multiple Myeloma 05/2024 - 02/2006
20	Neoplasms (Cancer) 01/2024 - 08/2007
7	Infections 01/2023 - 01/2020
6	Anemia 11/2022 - 10/2015
5	COVID-19 01/2023 - 01/2020
5	Lymphoma (Lymphomas) 01/2022 - 08/2007
5	Primary Myelofibrosis (Myelosclerosis) 11/2020 - 01/2014
5	Immunoglobulin Light-chain Amyloidosis 01/2019 - 04/2013
4	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2013
4	Paraproteinemias (Monoclonal Gammopathy) 01/2021 - 05/2006
3	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021 - 06/2012
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 06/2012
3	Frailty 01/2020 - 01/2016
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2018 - 01/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2022
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 06/2012
2	Genomic Instability 01/2022 - 01/2016
2	Fatigue 01/2021 - 11/2009
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2003
2	Smoldering Multiple Myeloma 01/2021 - 03/2016
2	Polycythemia Vera 11/2020 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2014
2	Splenomegaly 01/2018 - 01/2014
2	Disease Progression 01/2018 - 03/2016
2	Plasmacytoma 01/2017 - 08/2007
2	Monoclonal Gammopathy of Undetermined Significance 03/2016 - 06/2014
2	Bone Diseases (Bone Disease) 10/2015 - 06/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2012 - 04/2005
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2012 - 10/2005
1	Heart Diseases (Heart Disease) 10/2023
1	Toxic Optic Neuropathy 06/2023
1	Cytopenia 01/2023
1	cell-associated neurotoxicity 01/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023
1	Cytokine Release Syndrome 01/2023

Drug/Important Bio-Agent (IBA)

17	Bortezomib (Velcade)FDA Link 05/2024 - 08/2007
15	Dexamethasone (Maxidex)FDA LinkGeneric 05/2024 - 08/2007
12	Lenalidomide (CC 5013)FDA Link 11/2023 - 02/2012
9	carfilzomibIBA 11/2023 - 09/2017
8	Proteasome InhibitorsIBA 01/2024 - 09/2017
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
6	pomalidomideIBA 03/2023 - 01/2014
4	Immunomodulating AgentsIBA 03/2023 - 09/2017
4	Immunoglobulin G (IgG)IBA 01/2023 - 11/2009
3	selinexorIBA 05/2024 - 01/2019
3	Hemoglobins (Hemoglobin)IBA 10/2023 - 10/2015
3	daratumumabIBA 08/2023 - 01/2021
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 03/2016
3	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2023
3	LigandsIBA 11/2022 - 08/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 10/2018
3	Antimitotic AgentsIBA 01/2021 - 01/2013
3	Cyclin BIBA 01/2021 - 01/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 08/2007
3	Diphosphonates (Bisphosphonates)IBA 02/2017 - 06/2012
2	VaccinesIBA 01/2023 - 12/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2018
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2021
2	UbiquitinIBA 01/2022 - 01/2021
2	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 03/2018
2	ParaproteinsIBA 08/2021 - 11/2017
2	Bendamustine Hydrochloride FDA Link 01/2021 - 10/2012
2	Thalidomide (Thalomid)FDA Link 01/2021 - 09/2017
2	venetoclaxIBA 01/2021 - 01/2020
2	Anaphase-Promoting Complex-CyclosomeIBA 01/2021 - 12/2013
2	Monoclonal AntibodiesIBA 05/2020 - 01/2018
2	DiureticsIBA 01/2019 - 08/2002
2	ruxolitinibIBA 01/2018 - 01/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 06/2012
2	Rituximab (Mabthera)FDA Link 01/2017 - 10/2012
2	Caspofungin (Cancidas)FDA Link 02/2015 - 09/2012
2	posaconazole FDA Link 10/2013 - 09/2012
1	Chemokine ReceptorsIBA 01/2024
1	belantamab mafodotinIBA 06/2023
1	elotuzumabIBA 03/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	molnupiravirIBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023

Therapy/Procedure

38	Therapeutics 05/2024 - 08/2007
12	Stem Cell Transplantation 03/2024 - 02/2006
6	Drug Therapy (Chemotherapy) 11/2021 - 03/2006
4	Homologous Transplantation 11/2019 - 02/2012
3	Precision Medicine 01/2023 - 01/2020
3	Hematopoietic Stem Cell Transplantation 12/2021 - 01/2018
3	Blood Component Removal (Apheresis) 01/2021 - 01/2017
2	Transplantation 01/2021 - 06/2012
2	Immunotherapy 01/2018 - 01/2017
2	Cell Transplantation 01/2016 - 06/2012
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2007 - 03/2006
1	Drug Tapering 06/2023
1	Premedication 01/2023
1	Renal Dialysis (Hemodialysis) 01/2023